Skip to main content

Miller Brian Edward's Form 4 filing

Intuitive Surgical Inc (ISRG) · filed Mar 12, 2025

Accession no.
0001035267-25-000087
Filed
Mar 12, 2025
Trade date
Mar 11-12, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 3 derivative transactions. Open-market sales total $6.37M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Miller Brian EdwardCIK 0002010301Officer (EVP & Chief Digital Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 11, 2025Common StockMOption exerciseAcquired+1,834$177.99+$326,433.6614,658Direct
Mar 11, 2025Common StockSSaleDisposed−1,834$485.96F2−$891,250.6412,824Direct
Mar 11, 2025Common StockSSaleDisposed−442$482.82F3−$213,406.4412,382Direct
Mar 11, 2025Common StockSSaleDisposed−6,624$484.97F4−$3,212,441.285,758Direct
Mar 12, 2025Common StockMOption exerciseAcquired+1,550$177.99+$275,884.57,308Direct
Mar 12, 2025Common StockSSaleDisposed−1,550$512.06−$793,6935,758Direct
Mar 12, 2025Common StockMOption exerciseAcquired+2,450$208.90+$511,8058,208Direct
Mar 12, 2025Common StockSSaleDisposed−2,450$512.06−$1,254,5475,758Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 11, 2025Common StockMOption exerciseDisposed−1,834$0.00$01,550Direct
Mar 12, 2025Common StockMOption exerciseDisposed−1,550$0.00$00Direct
Mar 12, 2025Common StockMOption exerciseDisposed−2,450$0.00$04,317Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $479.78 to $489.50 as follows: 243 shares sold at $479.78 to $480.75; 200 shares sold at $480.99to $481.50; 100 shares sold at $483.59; 100 shares sold at $485.39; 791 shares sold at $487.20 to $488.09; and 400 shares sold at $488.52 to $489.50. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $480.67 to $489.28 as follows: 270 shares sold at $480.67 to $480.99; 100 shares sold at $483.59; and 72 shares sold at $489.28. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $478.45 to $490.19 as follows: 702 shares sold at $478.45 to $479.29; 1,330 shares sold at $480.41 to $481.13; 200 shares sold at $481.50 to $482.50; 500 shares sold at $482.76 to $483.03; 358 shares sold at $485.39 to $486.00; 2,377 shares sold at $487.20 to $488.09; 975 shares sold at $488.52 to $489.50; and 182 shares sold at $489.69 to $490.19. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)